The isoenzyme system for phosphorylating glucose
Isoenzymes usually differ in their kinetic properties, and the glucose-phosphorylating system is no exception. 
Kinetic characteristics of the four isoenzymes of vertebrate hexokinases
Note that only hexokinase D changes its activity appreciably over the ordinary range of glucose concentrations expected in hepatocytes. which is represented by the shaded region. The Figure is based on Figure 6 . I of ref. [6] , but the curve for hexokinase C is redrawn to give a more accurate representation of the degree of inhibition by excess substrate. Abbreviations used: MODY, maturity-onset diabetes of the young; NIDDM, non-insulin-dependent diabetes mellitus. Inhibition by glucose 6-phosphate A property often regarded as a special feature of hexokinase D is its lack of inhibition by glucose 6-phosphate, as its inhibition constant (around 60 mM) [24] is much higher than those of hexokinases A, B and C. However, a relative insensitivity to glucose 6-phosphate applies also to hexokinase C [7] , and it is now well established that the C-terminal half of hexokinases A and B contains the inhibitory site [5] , so the earlier arguments for an allosteric site in these hexokinases but not in hexokinase D ought now to be reconsidered.
In summary, and taking account of more evidence than I have mentioned here but which is fully discussed elsewhere [6] , hexokinase D is no more specific for glucose than the other isoenzymes, and the kinetic differences between the different isoenzymes most probably derive from quantitative differences in the rate constants and not from any fundamental differences of structure or mechanism.
Kinetics of hexokinase D with different sugar substrates
Liver hexokinase D shows kinetic co-operativity with respect to glucose and mannose, with a Hill coefficient of 1.5-1.6 [ 13,251, but Michaelian behaviour with fructose and 2-deoxyglucose [13, 19] ; the pancreatic rat enzyme shows similar kinetic characteristics [26, 27] . No co-operativity is observed with respect to MgATP [12] , but the degree of glucose co-operativity depends on the MgATP concentration [12, 13] and on the identity of the second substrate, no glucose co-operativity being observed with MgITP as nucleotide substrate, even at high concentrations [28] . Although the glucose co-operativity is very stable in many different conditions [13] , it can be suppressed by the presence of glycerol [29, 30] or competitive inhibitors [ 13,251. The alternative sugar substrates, mannose, fructose and 2-deoxyglucose, together with the analogue N-acetylglucosamine, all behave as competitive inhibitors with respect to glucose and they are all able to suppress co-operativity with glucose, although with different efficiencies [25] . The binary complex between the regulatory protein and fructose 6-phosphate also decreases co-operativity, albeit slightly [3 11 . Long-chain acyl-coenzymes A, on the other hand, which are partial competitive inhibitors of hexokinase D with respect to both glucose and MgATP, have no effect on glucose co-operativity [32] . The positive co-operativity observed in 'H20 is transformed to negative co-operativity if the assay is performed in 'H20 [33] . See ref. [6] for a general discussion.
The kinetic co-operativity with respect to glucose is of physiological importance, because combined with the high KO, (in the range of physiological glucose concentrations and higher than the level of circulating glucose before a carbohydrate meal), it could contribute to the regulation of the uptake of glucose in the hepatocyte and allow pancreatic hexokinase D to act as a glucose sensor [34] . It is a very well conserved feature through evolution, as the liver enzyme from all the vertebrate species so far studied shows the same kinetic behaviour as the rat enzyme, with essentially the same Hill coefficient (1.4-1.7) [11, 13, 35] , emphasizing its physiological importance. Therefore a recent report [23] that human pancreatic hexokinase D shows Michaelis-Menten behaviour with respect to mannose and co-operativity with respect to 2-deoxyglucose appears surprising. Given that the major structural features of the rat gene have been conserved in the human [36] , this result seems likely to derive from a problem with the analysis of the data, or from the use of an inadequate assay. Now that many mutants are available and their kinetic properties are used for correlaVolume 25 tion with structure, special care needs to be models in detail elsewhere [6] . Here I shall taken to use a valid assay and to analyse the data simply summarize their current status. in such a way that precise kinetic parameters can
The large degree of overlap between the be obtained.
predictions made by different models and the lack of experimental data in some crucial areas
Estimation of kinetk parameters
The 
Models for the kinetic co-operativity of hexokinase D with glucose
In addition to its probable physiological importance, the kinetic co-operativity of hexokinase D with respect to glucose has a second interest, as co-operativity is a very unusual property in a monomeric enzyme [40] . This kinetic co-operativity has attracted a considerable amount of attention, and I have discussed the various means that it is not yet possible to make a definitive choice of mechanism to explain the co-operativity of hexokinase D, but some important conclusions can still be drawn. First of all there can be no doubt that the co-operativity is kinetic in origin, especially as there is evidence that the binding of glucose is hyperbolic [29, 41] , and that it cannot be explained by a variant of one of the classic mechanisms. In this respect hexokinase D remains an outsider among enzymes with a significant degree of positive co-operativity, virtually all the others being oligomers with their co-operativity easily explainable in terms of subunit interactions. The second point is that there is good kinetic and spectroscopic evidence for the existence of different conformational states proposed four structural types of conformational change that could be slow enough to account for hysteretic mechanisms: (i) rotation or sliding of a-helices with respect to each other; (ii) cis-trans isomerization of proline residues; (iii) 'segmental rotation' of a relatively large portion of the protein; (iv) a 'hinged movement' of domains (cleft closure). Now that hexokinase D (native and mutants with selected properties) can be made available in large amounts, experiments can be undertaken that explore these different possibilities and help to define the model for kinetic co-operativity more precisely. 2 ) is a common metabolic disorder characterized by impaired insulin secretion in response to glucose and resistance of the target tissues to the action of insulin. T h e aetiology of NIDDM is not understood in detail, but it is known to involve both genetic and environmental factors, and it is classified among the multifactorial-polygenic syndromes. It is a major public health problem, affecting 5-7% of the world population. Although most forms of NIDDM do not exhibit simple Mendelian inheritance, familial clustering and the high rate of concordance in monozygote twins implicate genetic factors.
MODY, on the other hand, presents a Mendelian autosomal dominant transmission with high penetrance; it may account for as much as 10-15% of familial NIDDM. There is genetic heterogeneity amongst MODY patients as linkage studies have localized MODY genes on chromosomes 7, 12 and 20. T h e identities of the MODY loci on chromosomes 12 and 20 are not known. In about 50% of MODY patients the illness is associated with mutations encoding the hexokinase D locus [47-511. These mutations result in altered hexokinase D kinetic activity when they are reproduced by in vztm mutagenesis of a human islet cDNA and expressed in bacteria [38]. As it has been suggested that mutations in the hexokinase gene lead to the development of glucose intolerance by a gene-dose mechanism [51] it is very important to obtain the precise kinetic parameters for the mutants.
The reported mutations include nonsense, mis-sense and splicing-site mutations. T h e report of a nonsense mutation in exon 7 of the hexokinase D gene and its linkage with MODY was the first evidence implicating a mutation in a gene involved in glucose metabolism in the pathogenesis of NIDDM [SO]; shortly afterwards a mis-sense mutation was detected [51] . Muta- tions in the hexokinase D gene have been found not only in French families with MODY but also in British, Swedish and Afro-American patients, and thus appear not to be restricted to a particular ethnic group.
It is not known whether the diabetes in patients with MODY is caused by a deficiency in B-cell or in hepatic hexokinase D or both, as all the mutations found in humans so far occur in the region of the gene that is common to the two forms of the enzyme. T o try to answer this question, genetically modified mice have been produced with various combinations of alleles for normal and inactive hexokinase D, or with the liver or the pancreatic gene specifically eliminated [22,52,53]. T h e results are not very clear cut and different conclusions have been reached by the different authors. However, the data appear to favour the idea that both liver and pancreatic hexokinase D are implicated in MODY. 
